Long-term effects of weight-reducing diets in hypertensive patients

Institute for General Practice, Goethe University, Theodor-Stern-Kai 7, Frankfurt am Main, Germany, 60590.
Cochrane database of systematic reviews (Online) (Impact Factor: 6.03). 09/2011; 7(9):CD008274. DOI: 10.1002/14651858.CD008274.pub2
Source: PubMed


All major guidelines for antihypertensive therapy recommend weight loss. Thus dietary interventions that aim to reduce body weight might be a useful intervention to reduce blood pressure and adverse cardiovascular events associated with hypertension.
Primary objectivesTo assess the long-term effects of weight-reducing diets in hypertensive patients on- all cause mortality - cardiovascular morbidity - adverse events (including total serious adverse events, withdrawal due to adverse events and total non-serious adverse events)Secondary objectivesTo assess the long-term effects of weight-reducing diets in hypertensive patients on- change from baseline in systolic blood pressure - change from baseline in diastolic blood pressure - body weight reduction
Studies were obtained from computerised searches of Ovid MEDLINE, EMBASE, CENTRAL and from searches in reference lists and systematic reviews.
Randomised controlled trials (RCT) in adult hypertensive patients were included if they had a study duration of at least 24 weeks and compared weight reducing dietary interventions to no dietary intervention in adult patients with primary hypertension.
Two authors independently assessed risk of bias and extracted data. Studies were pooled using fixed-effect meta-analysis. In case of moderate or larger heterogeneity as measured by Higgins I(2), a random effects model was used.
Eight studies involving a total of 2100 participants with high blood pressure and a mean age of 45 to 66 years met our inclusion criteria. Mean treatment duration was 6 to 36 months. No study included mortality as a pre-defined outcome. One RCT evaluated the effects of dietary weight loss on a combined endpoint, consisting of the necessity of reinstating antihypertensive therapy and severe cardiovascular complications. In this RCT weight reducing diet lowered the endpoint, hazard ratio 0.70 (95% confidence interval [CI], 0.57 to 0.87) compared to no diet. None of the studies evaluated adverse events as designated in our protocol. Blood pressure was reduced in patients assigned to weight loss diets as compared to controls: systolic blood pressure (SBP): weighted mean difference (WMD): -4.5 mm Hg; 95% CI, -7.2 to -1.8 mm Hg (3 of 8 studies included in analysis), and diastolic blood pressure (DBP): WMD -3.2 mm Hg; 95% CI, -4.8 to -1.5 mm Hg (3 of 8 studies included in analysis). Patients' body weight was also reduced in dietary weight loss groups as compared to controls, WMD of -4.0 kg (95% CI: -4.8 to -3.2) (5 of 8 studies included in analysis). Two studies used withdrawal of antihypertensive medication as their primary outcome. Even though this was not considered a relevant outcome for this review, the results of these studies strengthen the finding of reduction of blood pressure by dietary weight loss interventions.
In patients with primary hypertension, weight loss diets reduced body weight and blood pressure, however the magnitude of the effects are uncertain as a result of the small number of patients and studies that could be included in the analyses. It is not known whether weight loss reduces mortality and morbidity. No useful information on adverse effects was reported in the relevant trials.

Download full-text


Available from: Andreas Waltering, Apr 24, 2014
  • Source
    • "In clinical practice, it is advisable to ask patients with T2DM what their previous maximal body weight was, and to calculate their MAXBMI and deltaBMI to estimate cardiovascular risk. From the epidemiological point of view, it is advisable to avoid obesity in young adults to reduce the risk of developing diabetes [32,33] as well as to reduce the risk for coronary heart disease [34,35]. It is also advisable to advise patients to undergo a medical check-up every year so as not to leave diabetes undiagnosed, untreated, or left poorly controlled. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Obesity is associated with insulin resistance, development of diabetes, and coronary heart disease. There is limited information on the contribution of previous obesity on the risk of coronary heart disease. We aimed to examine the effect of previous history of obesity on the occurrence of coronary heart disease in patients with diabetes. We carried out a retrospective chart analysis of 315 type 2 diabetic patients without obesity and without atherosclerotic cardiovascular events at their initial hospital visit (men/women 236/79; mean +/- standard deviation; age 53.1 +/- 6.6 years; maximal body mass index before enrollment (MAXBMI) 26.6 +/- 3.4 kg/m2; decrease of the BMI at enrollment from MAXBMI (deltaBMI) 4.23 +/- 2.62 kg/m2) to investigate the association of previous obesity (MAXBMI larger than 30 kg/m2) with the long-term incidence of cardiovascular events. Of 315 patients, forty-eight were previously obese. After median follow-up of 13.9 years, 48 patients developed coronary heart disease. The Kaplan-Meier analysis exhibited that coronary heart disease occurred more frequently in previously obese patients than in subjects in the reference category (22 kg/m2 < or = MAXBMI < 25 kg/m2) and that the effect lasted proportionally over follow-up periods. Multivariate Cox regression models showed that hazard ratios and corresponding 95% confidence intervals of coronary heart disease for patients with previous obesity compared with subjects in the reference category were 2.52 and 1.15 to 5.50 (p value = 0.020) after adjustment for age, sex, smoking status, systolic blood pressure, total cholesterol and HDL cholesterol. In this cohort, deltaBMI strongly correlated with MAXBMI and also behaved as a risk factor. The hazard ratios and 95% confidence intervals by the increment of one standard deviation of deltaBMI after adjustment for age, sex, smoking status, systolic blood pressure, total cholesterol and HDL cholesterol were 1.38 and 1.08 to 1.79 (p value = 0.013). Previous obesity and/or large body weight loss before admission might act as an increased risk for coronary heart disease.
    Full-text · Article · Oct 2013 · BMC Endocrine Disorders
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Introducción El presente trabajo supone el sexto documento elaborado por el Grupo de Prevención de las Enfermedades Cardio-vasculares del Programa de Actividades Preventivas y de Promoción de la Salud (PAPPS) 1-5 . Todos ellos conside-ran el riesgo cardiovascular como una herramienta básica para el establecimiento de las prioridades de prevención y para el tratamiento. La elaboración de unas recomendacio-nes generales para el tratamiento conjunto de los factores de riesgo cardiovascular constituye el objetivo común. Los grupos de trabajo de la Sociedad Española de Medicina de Familia y Comunitaria (semFYC) han elaborado aproxi-maciones más exhaustivas de cada uno de los factores de riesgo o de las enfermedades cardiovasculares.
    Full-text · Article · Jan 2009 · Atención Primaria
  • [Show abstract] [Hide abstract]
    ABSTRACT: Study aims were to identify the efficacy of lifestyle health promotion interventions intended to improve behavioural health risk factors and/or behavioural or clinical outcomes of working-age nurses. Nurses constitute around half the health workforce but global shortages and an ageing profile challenge future supply. The occupational hazards and stresses of nursing are well known. Health promotion, possibly workplace-based, presents opportunities to safeguard the health of nurses. This was a systematic review undertaken in line with guidance for reviews in health care. Seven electronic databases were searched from 2000-2011 and references of relevant papers. Two reviewers independently reviewed and critiqued retrieved papers and extracted data. Methodological features were described using the CONSORT checklists; risk of bias was assessed using the Cochrane Handbook classification. With design inclusion criteria relaxed to include an uncontrolled trial, only three intervention studies were retrieved, from the United States, Canada and Taiwan. All had limitations and high risk of bias, but benefits were reported. Outcomes included fewer cigarettes smoked during the intervention period, down from mean (SD) 20 (8)-12 (9) per day (p < 0·001); significantly reduced fat mass (0·68 vs. 0·07 kg; p = 0·028); and significant gains across a battery of fitness assessments. The paucity of work focused on nurses' health behaviours was the important finding. The workplace is a potentially fruitful location for health promotion intervention but nurses have seldom been recognised as a target participant group. Given the international priority ascribed to nursing workforce retention, this is a missed opportunity for occupational health planning. Potential benefits to nurses' welfare and well-being may accrue from well-designed intervention studies. Nurse leaders have a key role in driving recognition, spearheading commitment and development of targeted, whole-organisation programmes to promote health profile improvement for the nursing workforce.
    No preview · Article · Aug 2012 · Journal of Clinical Nursing
Show more